Journal: Cancer Communications
Article Title: Hypoxia-Induced Osteopontin-Positive Glioma-Associated Macrophages Facilitate Glioma Mesenchymal Transition via NF-κB Pathway Activation
doi: 10.34133/cancomm.0007
Figure Lengend Snippet: OPN facilitates the mesenchymal transition, migration, and proliferation of glioma cells. (A and B) Chord diagrams showing the correlations among SPP1 expression, CD44 expression, hypoxia score, mesenchymal score, GAM score, and proneural score in glioma samples from TCGA (A) and CGGA (B) datasets (red, positive correlation; green, negative correlation; the scale for each item represents the sum of the absolute values of the correlation coefficient of that item with the other items). (C to F) Distribution of SPP1 expression (C), hypoxia score (D), GAM score (E), and mesenchymal score (F) in samples from the IVY Glioblastoma Atlas dataset. (G) Spatial coexpression rate of SPP1 with hypoxia score, GAM score, and mesenchymal score in ZH_881 1A bulk spatial transcriptomic dataset. (H to K) Violin plots illustrating hypoxia score (H), GAM score (I), mesenchymal score (J), and proneural score (K) generated from RNA-seq data of BNI_2-4 cells cultured with the indicated CM ( n = 3 per group; control, standard growth medium for macrophages; THP-1-hypoCM, CM obtained from THP-1 cells cultured under hypoxic conditions for 24 h; U937-hypoCM, CM obtained from U937 cells cultured under hypoxic conditions for 24 h). ns, not significant, * P < 0.05, ** P < 0.01, *** P < 0.001. (L and M) Western blotting showing the expression levels of representative mesenchymal phenotype-related proteins (YKL40, EFEMP1, and CD44) in BNI_2-4 cells after culture with CM derived from THP-1 (L) and U937 (M) cells under different treatment conditions (normoxia, CM obtained from THP-1 or U937 cells cultured under normoxic condition for 24 h; Hypoxia, CM obtained from THP-1 or U937 cells cultured under hypoxic condition for 24 h; Hypo + siCtrl, CM obtained from siCtrl transfected THP-1 or U937 cells cultured under hypoxic condition for 24 h; Hypo + siSPP1-1, CM obtained from siSPP1-1 transfected THP-1 or U937 cells cultured under hypoxic condition for 24 h; Hypo + DMSO, CM obtained from THP-1 or U937 cells cultured under hypoxic condition for 24 h in the presence of DMSO; Hypo + OPNi-1, CM obtained from THP-1 or U937 cells cultured under hypoxic condition for 24 h in the presence of OPNi-1). (N) Transwell assays showing the migration of BNI_2-4 cells cultured with the indicated CM from THP-1 and U937 cells (scale bar = 100 μm). (O and P) Quantification of migrated BNI_2-4 cells cultured with indicated CM from THP-1 (O) and U937 (P) cells ( n = 5 per group). ** P < 0.01, *** P < 0.001. (Q and R) CCK-8 assays showing the proliferation of BNI_2-4 cells cultured with indicated CM from THP-1 (Q) and U937 (R) cells ( n = 5 per group). *** P < 0.001. The data are presented as the means ± SD. TCGA, The Cancer Genome Atlas; CGGA, Chinese Glioma Genome Atlas; SPP1, secreted phosphoprotein 1; CT, cellular tumor; HBV, hyperplastic blood vessels; IT, infiltrating tumor; LE, leading edge; MVP, microvascular proliferation; PNZ, perinecrotic zone; PAN, pseudopalisading cells around necrosis; CM, conditioned media; YKL40, chitinase-3 like protein 1; EFEMP1, EGF-containing fibulin extracellular matrix protein 1; CD44, cluster of differentiation 44; DMSO, dimethyl sulfoxide; OPNi-1, OPN expression inhibitor 1; kDa, kilodaltons.
Article Snippet: The mice were randomly assigned to the following 4 groups: the control group (treated with PBS), the OPNi-1 group (treated with 0.5 mg/kg OPNi-1, catalog no. HY-146064; MedChemExpress), the TMZ group (treated with 50 mg/kg TMZ, catalog no. HY-17364, MedChemExpress), and the TMZ + OPNi-1 group (treated with 50 mg/kg TMZ and 0.5 mg/kg OPNi-1).
Techniques: Migration, Expressing, Generated, RNA Sequencing, Cell Culture, Control, Western Blot, Derivative Assay, Transfection, CCK-8 Assay